Jüri Teras, Michael J. Carr, Jonathan S. Zager & Hidde M. Kroon. (2021) Molecular Aspects of the Isolated Limb Infusion Procedure. Biomedicines 9:2, pages 163.
Crossref
Akihisa Takahashi. 2016. Hyperthermic Oncology from Bench to Bedside. Hyperthermic Oncology from Bench to Bedside
91
108
.
Giammaria Fiorentini, Maurizio Cantore, Francesco Montagnani, Andrea Mambrini, Michelina D’Alessandro & Stefano Guadagni. 2016. Induction Chemotherapy. Induction Chemotherapy
61
71
.
Giammaria Fiorentini, Maurizio Cantore, Francesco Montagnani, Andrea Mambrini, Michelina D’Alessandro & Stefano Guadagni. 2013. Regionale Therapie maligner Tumoren. Regionale Therapie maligner Tumoren
55
64
.
Giammaria Fiorentini, Maurizio Cantore, Francesco Montagnani, Andrea Mambrini, Michelina D’Alessandro & Stefano Guadagni. 2011. Induction Chemotherapy. Induction Chemotherapy
59
69
.
Giammaria Fiorentini, Maurizio Cantore, Francesco Montagnani, Alfonso Del Freo, Stefano Guadagni & Gianfranco Baronzio. 2009. Cancer Microenvironment and Therapeutic Implications. Cancer Microenvironment and Therapeutic Implications
105
116
.
Sae Hee Ko, Tomio Ueno, Yasunori Yoshimoto, Jin Soo Yoo, Omar I. Abdel-Wahab, Zeinab Abdel-Wahab, Edward Chu, Scott K. Pruitt, Henry S. Friedman, Mark W. Dewhirst & Douglas S. Tyler. (2006) Optimizing a Novel Regional Chemotherapeutic Agent against Melanoma: Hyperthermia-Induced Enhancement of Temozolomide Cytotoxicity. Clinical Cancer Research 12:1, pages 289-297.
Crossref
Gian Franco Baronzio & E. Dieter HagerGiammaria Fiorentini, Ugo De Giorgi, Maurizio Cantore, Andrea Mambrini & Stefano Guadagni. 2006. Hyperthermia in Cancer Treatment: A Primer. Hyperthermia in Cancer Treatment: A Primer
156
163
.
Gian Franco Baronzio, Vincenzo Cerreta, Attilio Baronzio, Isabel Freitas, Marco Mapelli & Alberto Gramaglia. 2006. Hyperthermia in Cancer Treatment: A Primer. Hyperthermia in Cancer Treatment: A Primer
128
155
.
Faheez Mohamed, O. Anthony Stuart, Olivier Glehen, Muneyasu Urano & Paul H. Sugarbaker. (2004) Docetaxel and hyperthermia: Factors that modify thermal enhancement. Journal of Surgical Oncology 88:1, pages 14-20.
Crossref
H. Richard AlexanderJr.Jr.. (2003) Hyperthermia and its modern use in cancer treatment. Cancer 98:2, pages 219-221.
Crossref
N Zaffaroni, G Fiorentini & U De Giorgi. (2001) Hyperthermia and hypoxia: new developments in anticancer chemotherapy. European Journal of Surgical Oncology (EJSO) 27:4, pages 340-342.
Crossref
J. Jähne, P. Piso, E. Schmoll, R. Haulitschek-Hauss, H. Sterzenbach, H. Paul & R. Pichlmayr. (1997) Intraoperative (hypertherme) intraperitoneale Chemotherapie—Überlegungen und Aspekte zum sicheren intra- und postoperativen Umgang mit ZytostatikaIntraoperative (hyperthermic) intraperitoneal chemotherapy—Considerations and aspects for the safe intra- and postoperative use of cytostatic agents. Langenbecks Archiv für Chirurgie 382:1, pages 8-14.
Crossref
H. Richard Alexander, Douglas L. Fraker & David L. Bartlett. (1996) Isolated limb perfusion for malignant melanoma. Seminars in Surgical Oncology 12:6, pages 416-428.
Crossref
L. Orlandi, N. Zaffaroni, A. Bearzatto, A. Costa, R. Supino, M. Vaglini & R. Silvestrini. (2008)
Effect of melphalan and hyperthermia on cell cycle progression and cyclin B
1
expression in human melanoma cells
. Cell Proliferation 28:11, pages 617-630.
Crossref
Judith Leibovici, Geula Klorin, Ofer Klein & Moshe Michowitz. (1995) Correlation between Malignancy Level of AKR Lymphoma Variants and Sensitivity to Hyperthermia. Cancer Biotherapy 10:1, pages 53-60.
Crossref